Voyager Therapeutics Stock News

Novel intravenous (IV) vectorized antibody approach designed to activate innate immune system, destroy metastatic breast cancer tumors, and inhibit tumor progression in CNS

Voyager Therapeutics Inc (NASDAQ: VYGR) announced preclinical data from a new vectorized anti-HER2 antibody program. Data showed that IV dosing of a proprietary AAV vector identified by the TRACER

CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (

CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AAV) platform technologies, today announced it will present preclinical data from its vectorized antibody program at the 26 th Society for Neuro-Oncology (SNO) Annual Meeting on Nov. 19, 2021.

CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AA

5 short squeeze penny stocks to buy for under $5. Are they worth the risk?

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 10.67% and -25.90%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the sto

If you're like most traders right now, you're looking for an edge.… The post Best Penny Stocks To Buy For A Short Squeeze?

Are these high volume biotech penny stocks worth adding to your watchlist right now? The post Top Biotech Penny Stocks to Watch With High Volume Right Now appeared first on Penny Stocks to Buy, Picks,

Investors need to pay close attention to Voyager (VYGR) stock based on the movements in the options market lately.

The stock price of Voyager Therapeutics Inc (NASDAQ: VYGR) increased by over 4% pre-market today. This is why it happened.

Here's the big licensing news that's sending shares of VYGR stock higher today as investors reassess this company's value moving forward. The post VYGR Stock: The Huge Licensing Deal Sending Voyager T

Voyager Therapeutics Inc (NASDAQ: VYGR) announced that the group had inked a license option agreement that allows Pfizer Inc. (NYSE: PFE). As news of the deal became official and was doing the rounds,

The stock price of Voyager Therapeutics Inc (NASDAQ: VYGR) increased by over 50% pre-market today. This is why it happened.

Shares of a small biotech called Voyager Therapeutics surged after the company said Pfizer had licensed access to its gene therapy technology in a deal worth up to $630 million.